Delivery Order SPE2DB24D1104-SPE2DB25FYEV2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lidocaine 5% Patch 30S with a ceiling value of $10,877.33. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $5,418.73. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with a ceiling value of $1,774.71 under a firm fixed-price contract type. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under a larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,504.37 for Lidocaine 5% Patch (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,264.98 for Lidocaine 5% Patch 30s on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a delivery order valued at $2,722.08 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lidocaine 5% Patch 30s, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $4,131.60 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 3, 2025. This contract reflects a firm fixed price arrangement with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s with a ceiling value of $13,281.32. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without set-aside restrictions. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,722.08 delivery order to AmerisourceBergen Drug Corp for 30 units of Lidocaine 5% Patch on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units, with a ceiling value of $2,722.08. This competitively awarded, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of September 10, 2025. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYEV2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S pharmaceutical supplies on August 21, 2025, with a ceiling value of $9,627.27 under a firm fixed-price contract type. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order was awarded through open competition with no set-aside designation, reflecting the contractor's competitive capability in federal medical procurement. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply requirements across multiple therapeutic domains, positioning the company as a critical vendor for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 8/21/25 |